Results of a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas with PET and CA19-9 correlates

被引：0
|
作者：
Von Hoff, Daniel D.
Ervin, Thomas J.
Arena, Francis P.
Chiorean, E. Gabriela
Infante, Jeffrey R.
Moore, Malcolm J.
Seay, Thomas E.
Tjulandin, Sergei
Ma, Wen Wee
Saleh, Mansoor N.
Harris, Marion
Reni, Michele
Ramanathan, Ramesh K.
Tabernero, Josep
Hidalgo, Manuel
Van Cutsem, Eric
Goldstein, David
Wei, Xinyu
Iglesias, Jose Luis
Renschler, Markus Frederic
机构：
[1] Scottsdale Healthcare TGen, Virginia G Piper Canc Ctr Clin Trials, Scottsdale, AZ USA
[2] Florida Canc Specialists, Englewood, FL USA
[3] Arena Oncol Associates, Lake Success, NY USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Sarah Cannon Res Inst, Nashville, TN USA
[6] Tennessee Oncol, Nashville, TN USA
[7] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[8] Atlanta Canc Care, Atlanta, GA USA
[9] Russian Acad Med Sci, NN Blokhin Canc Res Ctr, Moscow, Russia
[10] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[11] Georgia Canc Specialists PC, Atlanta, GA USA
[12] Southern Hlth, East Bentleigh, Vic, Australia
[13] Univ Milan, Osped San Raffaele, Ist Ricovero & Cura Carattere Sci, I-20127 Milan, Italy
[14] Scottsdale Healthcare TGen, Virginia G Piper Canc Ctr, Scottsdale, AZ USA
[15] Vall dHebron Univ Hosp, Barcelona, Spain
[16] Ctr Integral Oncol Clara Campal, Madrid, Spain
[17] Katholieke Univ Leuven Hosp, Louvain, Belgium
[18] Prince Wales Hosp, Sydney, NSW, Australia
[19] Celgene Corp, Summit, NJ USA
[20] Bionomics Ltd, Thebarton, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4005
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Reduction in primary pancreatic and metastatic tumor burden in the phase III MPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone.
    Kunzmann, Volker
    Ramanathan, Ramesh K.
    Goldstein, David
    Penenberg, Darryl Neil
    Ferrara, Stefano
    Lu, Brian D.
    Von Hoff, Daniel D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] NAB-PACLITAXEL PLUS GEMCITABINE VS GEMCITABINE ALONE FOR PATIENTS WITH METASTATIC PANCREATIC CANCER: INFLUENCE OF PRIMARY PANCREATIC TUMOR LOCATION ON EFFICACY AND TREATMENT EXPOSURE IN THE MPACT PHASE III TRIAL
    Jose, Lopez-Martin
    Wee, Ma Wen
    Christos, Karapetis
    Peter, Balcke
    Hagan, Kennecke
    Michael, Stahl
    Michele, Milella
    Francis, Nugent
    Diane, Prager
    Brian, Lu
    Stefano, Ferrara
    Darryl, Penenberg
    Daniel, Von Hoff
    ANNALS OF ONCOLOGY, 2014, 25 : 28 - 28
  • [23] SUBGROUP ANALYSES BASED ON LIVER METASTASES AND THE NUMBER OF METASTATIC SITES FROM THE MPACT PHASE III TRIAL OF NAB-PACLITAXEL PLUS GEMCITABINE VS GEMCITABINE ALONE FOR METASTATIC PANCREATIC CANCER
    Colin, Weekes
    Francis, Parnis
    Josef, Thaler
    Hans, Prenen
    Richard, Letourneau
    Eric, Raymond
    Armando, Santoro
    Garcia-Carbonero, Rocio
    John, Weis
    Alfredo, Romano
    Desmond, McGovern
    Darryl, Penenberg
    Daniel, Von Hoff
    ANNALS OF ONCOLOGY, 2014, 25 : 29 - 29
  • [24] Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
    Van Cutsem, Eric
    Tempero, Margaret A.
    Sigal, Darren
    Oh, Do-Youn
    Fazio, Nicola
    Macarulla, Teresa
    Hitre, Erika
    Hammel, Pascal
    Hendifar, Andrew E.
    Bates, Susan E.
    Li, Chung-Pin
    Hingorani, Sunil R.
    de la Fouchardiere, Christelle
    Kasi, Anup
    Heinemann, Volker
    Maraveyas, Anthony
    Bahary, Nathan
    Layos, Laura
    Sahai, Vaibhav
    Zheng, Lei
    Lacy, Jill
    Park, Joon Oh
    Portales, Fabienne
    Oberstein, Paul
    Wu, Wilson
    Chondros, Dimitrios
    Bullock, Andrea J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (27) : 3185 - +
  • [25] Nab-Paclitaxel Plus Gemcitabine vs Gemcitabine Alone for Resected Pancreatic Cancer in a Phase III Trial (APACT)
    Tempero, Margaret
    Cardin, Dana
    Biankin, Andrew V.
    Goldstein, David
    Moore, Malcolm
    O'Reilly, Eileen
    Philip, Philip
    Riess, Hanno
    Macarulla, Teresa
    Yung, Lotus
    Li, Mingyu
    Lu, Brian
    GASTROENTEROLOGY, 2015, 148 (04) : S944 - S944
  • [26] Low-dose gemcitabine plus nab-paclitaxel versus standard-dose gemcitabine plus nab-paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase II trial
    Kamata, Ken
    Imai, Hajime
    Matsumoto, Hisakazu
    Yamashita, Yukitaka
    Kato, Takao
    Nishi, Katsuhisa
    Omoto, Shunsuke
    Minaga, Kosuke
    Yamao, Kentaro
    Hyodo, Tomoko
    Im, Sung-Woon
    Hara, Akane
    Yoshikawa, Tomoe
    Ishikawa, Rei
    Okamoto, Ayana
    Yamazaki, Tomohiro
    Nakai, Atsushi
    Ueshima, Kazuomi
    Chiba, Yasutaka
    Takenaka, Mamoru
    Watanabe, Tomohiro
    Kitano, Masayuki
    Kudo, Masatoshi
    JGH OPEN, 2023, 7 (09): : 659 - 666
  • [27] Phase III study of nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone in patients (pts) with metastatic pancreatic adenocarcinoma (mPC): Subgroup analysis of Canadian pts from the MPACT trial
    Tehfe, Mustapha Ali
    Dowden, Scot D.
    Kennecke, Hagen F.
    El-Maraghi, Robert Hassan
    Lesperance, Bernard
    Couture, Felix
    Letourneau, Richard
    Penenberg, Darryl Neil
    Romano, Alfredo
    Von Hoff, Daniel D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [28] RESULTS OF A PHASE 1/2 STUDY OF NAB-PACLITAXEL PLUS GEMCITABINE IN PATIENTS WITH ADVANCED PANCREATIC CANCER WITH SPARC AND CA19-9 CORRELATIVES
    Ramanathan, R.
    Borad, M.
    Laheru, D.
    Smith, L.
    Wood, T. E.
    Korn, R. L.
    Desai, N.
    Iglesias, J.
    Hidalgo, M.
    von Hoff, D. D.
    ANNALS OF ONCOLOGY, 2010, 21 : 234 - 234
  • [29] Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial
    Dorman, Klara
    Boeck, Stefan
    Caca, Karel
    Reichert, Maximilian
    Ettrich, Thomas J.
    Oettle, Helmut
    Waidmann, Oliver
    Modest, Dominik P.
    Mueller, Lothar
    Michl, Patrick
    Kanzler, Stephan
    Pink, Daniel
    Reinacher-Schick, Anke
    Geissler, Michael
    Pelz, Henning
    Kunzmann, Volker
    Held, Swantje
    Schichtl, Thomas
    Heinemann, Volker
    Kullmann, Frank
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (10): : 935 - 943
  • [30] Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)
    Goldstein, David
    Von Hoff, Daniel D.
    Moore, Malcolm
    Greeno, Edward
    Tortora, Giampaolo
    Ramanathan, Ramesh K.
    Macarulla, Teresa
    Liu, Helen
    Pilot, Richard
    Ferrara, Stefano
    Lu, Brian
    EUROPEAN JOURNAL OF CANCER, 2016, 52 : 85 - 91
12345